Why are novel psychoactive substances challenging toxicologists?
The last decade has seen a rapid and continuous growth of novel psychoactive substances (NPS), a range of drugs that have been designed to imitate the effects of established illicit drugs. Mainly sold over the Internet, NPS have created a challenge for doctors, toxicologists, and drug testing laboratories.
An uncontrolled proliferation
Abuse of novel psychoactive substances (NPS) has increased significantly in recent years and many drugs within this class are now well established as recreational drugs. Dominating groups of NPS reported are synthetic cannabinoids and cathinones, substances known as “legal highs”, “recreational drugs”, “designer drugs”, “smart drugs”, “spice”, “bath salts”, etc. The majority are stimulants, followed by synthetic cannabinoid and classic hallucinogens with a notable increase in synthetic opioids in recent years.
Often, little is known about the adverse health effects and social harms of NPS, which pose a considerable challenge for prevention and treatment.
The proliferation of these substances presents a variety of challenges from both a public health and public safety standpoint. Synthesized as analogs of existing drugs to bypass laws and regulations, they generally have the same or even higher effects than the compounds they derive from. Producers of these substances develop new chemicals to replace those that are banned, which means that the chemical structures of the drugs are constantly changing to try to stay ahead of the law. These compounds often exhibit only minor structural modifications in comparison to conventional drugs but can be legally traded until national restrictions are put in place.
According to the literature, NPS often possess higher receptor-binding affinities in contrast to classical recreational drugs thus most probably resulting in higher potency and, very often, increased levels of undesired side effects.
A lack of knowledge
Toxicological knowledge regarding novel psychoactive substances is still poor: little data about their toxicity is available with consequent unexpected and unknown health risks.
Effects of synthetic cathinones are like those of other stimulants and may include increased energy, mood enhancement, exhilaration and psychoactive effects. Adverse effects include panic attacks, tremors, depression, and psychosis. Synthetic cathinones are also associated with neurological, cardiovascular and psychopathological symptoms such as tachycardia, hallucinations, delusions, violence, aggressive tendencies, and death.
.
Purity and composition of products containing NPS are often not known, which places users at high risk. To date, some fatalities related to NPS use have been reported worldwide, and up to recently, more than 1000 substances have been reported.
The identification of NPS in biological fluids/tissues is of great concern for forensic and clinical toxicologists, to evaluate their spread among the population and to diagnose intoxication and impairment due to the use of these substances. Timely and accurate detection of NPS is foundational for their effective clinical and social management.
A greater need of training
The identification of novel psychoactive substances in biological fluids contributes to the effectiveness of the therapeutic management of intoxicated patients. Nonetheless, several difficulties are related to the identification of these compounds in biological samples, such as many potential structures, the constant introduction of novel compounds, and the initial lack of reference standards.
To meet the complexity of novel psychoactive substances issue, scientists and health professionals must benefit from solid training. The Master of Advanced Studies (MAS) in Toxicology provides a comprehensive educational programme recognised by national and international professional bodies as a postgraduate academic qualification in toxicology. The programme fulfills the demand for qualified toxicologists in industry, academia and regulatory bodies with the appropriate knowledge, experience, and professional qualification.
In addition to NPS, other topics of major concern such as endocrine disruptors, the impact of pollutants on the environment, food safety and occupational health, are also covered in this training programme.
References
- S.Lehmann, T.Kielibaa, J.Beikea et al.; Journal of Chromatography B 1064 (2017) 124–138
- Abu Shafi, Alex J. Berry, Harry Sumnall, David M. Wood and Derek K. Tracy
Therapeutic Advances in Psychopharmacology 2020, Vol. 10: 1–21 - Tonje Gottenberg Skaalvik, Elisabeth Leere Øiestad, Roger Trones et al. Journal of Chromatography B Volume 1183, (2021) 122926
- La Maida, Nunzia; Di Giorgi, Alessandro; Pichini, Simona et al. ; Therapeutic Drug Monitoring. 46(2):203-209, April 2024
- European Monitoring Centre for Drugs and Drug Addiction (2023), European Drug Report 2023: Trends and Developments,
- UNODC (United Nations Office on Drugs and Crime): Early Warning Advisory (EWA) on New Psychoactive Substances (NPS)